Birla Fertility & IVF to Invest Rs 500 Crore for Expansion into Southern India
Birla Fertility & IVF, a prominent player in the fertility industry and part of the USD 3-billion CK Birla Group, has announced a significant investment of Rs 500 crore over the next 2-3 years. This
Birla Fertility & IVF, a prominent player in the fertility industry and part of the USD 3-billion CK Birla Group, has announced a significant investment of Rs 500 crore over the next 2-3 years. This strategic move is aimed at capturing a larger share of the domestic market and bolstering the company’s presence in southern India.
As the third-largest fertility chain in the country, Birla Fertility & IVF plans to expand its footprint by establishing 10-12 new centers across key southern states, including Karnataka, Tamil Nadu, Kerala, Telangana, and Andhra Pradesh, within the next 12-24 months. This expansion reflects the company’s commitment to broadening its reach, particularly in Tier II and Tier III cities.
Avanti Birla, Chairman and Founder of Birla Fertility & IVF, emphasized the company’s goal: “By investing heavily in infrastructure and leveraging our expertise, we aim to provide fertility solutions to a wider audience, particularly in underserved regions. Our focus is on delivering exceptional care and achieving superior pregnancy rates that meet international standards.”
The recent acquisition of two fertility clinic chains, BabyScience and ARMC IVF, further supports Birla Fertility & IVF’s growth strategy. This move has expanded the company’s network to 50 clinics nationwide, making it the third-largest fertility chain in India. The acquisition includes 12 BabyScience clinics predominantly in Karnataka, Maharashtra, and Tamil Nadu.
Abhishek Aggrawal, Chief Business Officer at Birla Fertility & IVF, noted, “Our expansion across India, driven by both acquisitions and organic growth, underscores our commitment to leveraging global expertise and infrastructure to enhance our service delivery.”
Looking ahead, Birla Fertility & IVF aims to achieve its ambitious goal of establishing 100 clinics by FY28. This will be pursued through a blend of strategic acquisitions, organic growth, and partnerships.
The company’s latest investment and expansion plans signal a robust growth trajectory and reinforce its dedication to becoming a leading provider of fertility solutions in India.
